pharmacokinetic - Robuta Search

https://www.epistemonikos.org/en/documents/c1743636e8de798797eef76580a61c750a344e38 Exploratory Pilot Study to Evaluate the Pharmacokinetic Profile of Magaldrate The goal of this clinical pilot study is to evaluate the pharmacokinetic profile of magaldrate in a group of 10 healthy women, after the administration of a ... pilot study exploratory evaluate pharmacokinetic profile https://www.page-meeting.org/Abstracts/pharmacokinetic-analysis-of-midazolam-and-caffeine-as-probe-drugs-for-cytochrome-phenotyping-in-erlotinib-treatment/ Pharmacokinetic analysis of midazolam and caffeine as probe drugs for cytochrome phenotyping in... Oct 21, 2025 - Poster: Drug/Disease modeling - Oncology - Pharmacokinetic analysis of midazolam and caffeine as probe drugs for cytochrome phenotyping in erlotinib treatment https://about.uq.edu.au/experts/project/31615 A prospective observational pharmacokinetic evaluation of the plasma and cerebrospinal fluid... of the prospective observational pharmacokinetic evaluation https://pure.jbnu.ac.kr/en/publications/pharmacokinetic-interactions-between-tegoprazan-and-naproxen-acec-2/ Pharmacokinetic interactions between tegoprazan and naproxen, aceclofenac and celecoxib in healthy... pharmacokinetic interactions naproxen aceclofenac celecoxib https://www.page-meeting.org/Abstracts/building-of-a-virtual-paediatric-cancer-population-for-physiologically-based-pharmacokinetic-modelling-and-simulation-in-neonates-infants-and-children/ Building of a virtual paediatric cancer population for physiologically-based pharmacokinetic... Oct 21, 2025 - Poster: Drug/Disease modeling - Paediatrics - Building of a virtual paediatric cancer population for physiologically-based pharmacokinetic modelling and... paediatric cancer building virtual https://researchers.mq.edu.au/en/publications/pharmacokinetic-and-pharmacodynamic-comparison-of-once-daily-efav/fingerprints/?sortBy=alphabetically Pharmacokinetic and pharmacodynamic comparison of once-daily efavirenz (400 mg vs. 600 mg) in... https://adisinsight.springer.com/trials/700196275?error=cookies_not_supported&code=4737b0ef-8685-4fcf-ab05-9f30fa0750de A Parallel, Three Arm, Open-label, Multi-dose Pharmacokinetic Study of Dalfampridine-ER 7.5 mg... This trial will investigate the pharmacokinetics of fampridine in volunteers and patients with mild and moderate renal impairment. The primary endpoint is the https://alicantobidmc.org/resources/proactive-infliximab-optimization-using-pharmacokinetic-dashboard-versus-standard-care Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in... standard of care https://www.trialx.com/clinical-trials/listings/321450/safety-tolerability-and-pharmacokinetic-characteristics-of-sss11-in-patients-with-gout-and-hyperuricemia/ Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and... Clinical trial for Gout | Hyperuricemia , Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia in patients safety tolerability pharmacokinetic characteristics https://www.wapcpjournal.org.ng/index.php/home/article/view/30?articlesBySimilarityPage=2 Insights into the pharmacokinetic interactions between antimicrobial and antimalarial drugs... insights pharmacokinetic interactions antimicrobial antimalarial https://www.walshmedicalmedia.com/proceedings/diosmetin-pharmacokinetic-following-diosmin-oral-administration-in-man-a-new-study-on-an-old-product-with-controversial-pharmacokinetic-findings-in-th-20390.html Diosmetin pharmacokinetic following diosmin oral administration i | 20390 S everal flavonoids are used in therapy with a wide range of indications; almost all are of natural origin and many products are employed in the popular ..20390 oral administration pharmacokinetic following diosmin https://www.page-meeting.org/Abstracts/physiologically-based-pharmacokinetic-modeling-for-sub-saharan-african-populations-a-review-of-system-parameters-and-variability-drivers/ PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING FOR SUB-SAHARAN AFRICAN POPULATIONS: A REVIEW OF... May 12, 2026 - Background. Physiologically based pharmacokinetic (PBPK) models generate exposure predictions from drug-specific parameters interacting with system... sub saharan https://bjbmb.org/index.php/bjbmb/article/view/59/34 View of Molecular Docking and Pharmacokinetic Profiling of Dimethyl ellagic acid from Eucalyptus... molecular docking https://experts.mcmaster.ca/scholarly-works/2152493 Derivation of a Pharmacokinetic Model to Include a... Learn about the scholarly work entitled Derivation of a Pharmacokinetic Model to Include a... pharmacokinetic model include https://adisinsight.springer.com/trials/700315600?error=cookies_not_supported&code=f62e8d5f-4106-41e3-ad08-99c6ae2ed150 A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males - AdisInsight This is a Phase I, open-label, two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males. https://trinidadtobagostemnews.com/article/889559394-alvotech-announces-positive-top-line-results-from-pivotal-pharmacokinetic-study-for-proposed-biosimilar-to-entyvio Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed... top line results from https://www.page-meeting.org/Abstracts/nintedanib-physiologically-based-pharmacokinetic-pbpk-model-to-predict-drug-drug-interactions/ Nintedanib physiologically based pharmacokinetic (PBPK) model to predict drug-drug interactions nintedanib based pharmacokinetic pbpk model https://www.page-meeting.org/Abstracts/using-pharmacokinetic-simulation-to-guide-dose-escalation-decisions-for-targeted-il2v-immunocytokines/ Using pharmacokinetic simulation to guide dose escalation decisions for targeted IL2v... Oct 21, 2025 - Oral: Clinical Applications - Using pharmacokinetic simulation to guide dose escalation decisions for targeted IL2v immunocytokines using pharmacokinetic simulation guide https://medicalslotter.com/pharmacokinetic-drug-interactions-explained-for-patients-what-you-need-to-know Pharmacokinetic Drug Interactions Explained for Patients: What You Need to Know Learn how one medication can change how another moves through your body-causing dangerous side effects or making treatments fail. This guide explains... what you need drug interactions for patients pharmacokinetic explained https://www.paganz.org/abstracts/a-population-pharmacokinetic-model-of-once-daily-intravenous-busulfan-in-paediatrics-characterising-time-dependent-clearance/ A population pharmacokinetic model of once daily intravenous busulfan in paediatrics characterising... Feb 1, 2021 - Aims: To characterise the pharmacokinetics of busulfan in paediatrics and investigate changes in clearance over a 4-day treatment course of once daily... model of https://repositori.urv.cat/estatic/PC0011/en_imarina4683713.html Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and... DEHP exposure to human comes from different sources such as food, diet, cosmetics, toys, medical products, and food wraps. Recently, DEHP was categorized as... https://www.page-meeting.org/Abstracts/population-pharmacokinetic-and-pharmacodynamic-modeling-of-canagliflozin-in-paediatric-patients-with-type-2-diabetes-mellitus/ Population Pharmacokinetic and Pharmacodynamic Modeling of Canagliflozin in Paediatric Patients... May 12, 2026 - Introduction: Type 2 diabetes mellitus (T2DM) is a chronic, progressive metabolic disorder that impacts patients across a broad age range... population pharmacokinetic modeling canagliflozin paediatric https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.912202/full Frontiers | Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity... Introduction: Therapeutic drug monitoring (TDM) and pharmacokinetic assessments of vancomycin would be essential to avoid vancomycin-associated nephrotoxicit... critically ill frontiers pharmacokinetic assessment vancomycin https://www.page-meeting.org/Abstracts/population-pharmacokinetic-analysis-of-oral-intramuscular-immediate-release-and-subcutaneous-long-acting-injectable-olanzapine/ POPULATION PHARMACOKINETIC ANALYSIS OF ORAL, INTRAMUSCULAR IMMEDIATE RELEASE AND SUBCUTANEOUS... May 12, 2026 - Introduction/Objectives: Olanzapine is an antipsychotic drug used in the treatment of schizophrenia with oral (PO) and intramuscular (IM) formulations... immediate release population pharmacokinetic analysis oral https://www.simulations-plus.com/resource/bridging-inhaled-aerosol-dosimetry-to-physiologically-based-pharmacokinetic-modeling-for-toxicological-assessment-nicotine-delivery-systems-and-beyond/ Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for... bridging aerosol dosimetry based pharmacokinetic https://researchers.westernsydney.edu.au/en/publications/bayesian-methods-for-pharmacokinetic-pharmacodynamic-modeling-of-/ Bayesian methods for pharmacokinetic/ pharmacodynamic modeling of pazopanib-induced increases in... bayesian methods pharmacokinetic https://www.natap.org/2025/CROI/croi_07.htm Pharmacokinetic Modeling of Missed Dose Scenario of Oral Weekly Islatravir Plus Lenacapavir pharmacokinetic modeling missed dose https://kar.kent.ac.uk/37710/ How to fit pharmacodynamic and pharmacokinetic non-linear mixed effects models in S-Plus:... how to fit https://www.page-meeting.org/Abstracts/ode-free-survival-modeling-with-full-pharmacokinetic-profiles-in-the-impres-m-framework/ ODE-free survival modeling with full pharmacokinetic profiles in the IMPRES-M framework Oct 21, 2025 - Poster: Methodology - New Modelling Approaches - ODE-free survival modeling with full pharmacokinetic profiles in the IMPRES-M framework https://pure.jbnu.ac.kr/en/publications/pharmacokinetic-interactions-between-telmisartanamlodipine-and-ro/ Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral... pharmacokinetic interactions telmisartan amlodipine rosuvastatin https://researchconnect.buffalo.edu/en/publications/a-population-pharmacokinetic-pharmacodynamic-analysis-and-model-v/ A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide - SUNY... model validation population pharmacokinetic analysis https://jp.certara.com/publication/population-pharmacokinetic-model-for-a-novel-oral-hypoglycemic-formed-in-vivo-comparing-the-use-of-active-metabolite-data-alone-versus-using-data-of-upstream-and-downstream-metabolites/ Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of... Jun 4, 2025 - The purpose of this analysis was to develop a population pharmacokinetic model for CS-917, an oral hypoglycemic prodrug, and its 3 metabolites. The https://iris.unical.it/handle/20.500.11770/341719 Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and... anticancer drugs recent strategies improve stability https://researchconnect.buffalo.edu/en/publications/mechanism-based-pharmacokineticpharmacodynamic-model-of-parathyro/ Mechanism-based pharmacokinetic/pharmacodynamic model of parathyroid hormone-calcium homeostasis in... model of parathyroid hormone calcium homeostasis mechanism based https://www.page-meeting.org/Abstracts/pharmacokinetic-optimization-of-valganciclovir-and-ganciclovir-therapy-in-lung-transplant-recipients/ Pharmacokinetic optimization of valganciclovir and ganciclovir therapy in lung transplant recipients Oct 23, 2025 - Poster: Clinical Applications - Pharmacokinetic optimization of valganciclovir and ganciclovir therapy in lung transplant recipients lung transplant pharmacokinetic optimization valganciclovir https://pubchem.ncbi.nlm.nih.gov/bioassay/11928 AID 11928 - Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg - PubChem BioAssay record AID 11928 submitted by ChEMBL: Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg. https://topmostchemical.com/pharmacokinetic-profiling-of-123847-85-8-understanding-absorption-distribution-metabolism-and-excretion-adme/ Pharmacokinetic Profiling Of 123847-85-8: Understanding Absorption, Distribution, Metabolism, And... May 8, 2024 - Learn about the pharmacokinetic profiling of 123847-85-8, including absorption, distribution, metabolism, and excretion (ADME). pharmacokinetic profiling https://www.page-meeting.org/Abstracts/a-population-pharmacokinetic-study-of-alminoprofen-penetration-into-synovial-fluid/ A Population Pharmacokinetic Study Of Alminoprofen Penetration Into Synovial Fluid Oct 21, 2025 - poster - A Population Pharmacokinetic Study Of Alminoprofen Penetration Into Synovial Fluid population pharmacokinetic study penetration fluid https://experts.mcmaster.ca/scholarly-works/1551435 Pharmacokinetic and pharmacodynamic interactions... Learn about the scholarly work entitled Pharmacokinetic and pharmacodynamic interactions... pharmacokinetic interactions https://sciencepublishinggroup.com/article/10.11648/j.ajche.20261401.11 Synthesis and Pharmacokinetic Evaluation of Novel Bioactive Organic Compounds, American Journal of... organic compounds synthesis pharmacokinetic evaluation https://www.walshmedicalmedia.com/abstract/pharmacokinetic-changes-secondary-to-roux-en-y-gastric-bypass-6880.html Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypas | 6880 Objective: To review the influence of Roux-en-Y gastric bypass (RYGB) on pharmacokinetic parameters of medications. Data sources: PubMed was searched fro..6880 pharmacokinetic changes secondary roux en https://www.page-meeting.org/Abstracts/a-translational-semi-mechanistic-pharmacokinetic-pharmacodynamic-framework-to-design-animal-studies-application-to-linezolid-and-vancomycin/ A translational semi-mechanistic pharmacokinetic-pharmacodynamic framework to design animal... Oct 21, 2025 - Poster: Drug/Disease Modelling - Infection - A translational semi-mechanistic pharmacokinetic-pharmacodynamic framework to design animal studies: Application... translational semi pharmacokinetic framework design https://toxstrategies.com/publications/evaluation-and-optimization-of-pharmacokinetic-models-for-in-vitro-to-in-vivo-extrapolation-of-estrogenic-activity-for-environmental-chemicals/ Evaluation and optimization of pharmacokinetic models for in vitro to in vivo extrapolation of... Jan 30, 2026 - Casey WM, Chang X, Allen DG, Ceger PC, Choksi NY, Hsieh JH, et al. 2018. Evaluation and optimization of pharmacokinetic models for in... read more https://uwspace.uwaterloo.ca/items/d0af2bd0-df61-4ed1-8210-d8296d292d51 Pharmacokinetic and economic implications when switching between hemophilia A treatments Hemophilia is a bleeding disorder in which the blood is unable to form clots, and is also classified as severe (defined as having an endogenous factor VIII... economic implications pharmacokinetic switching hemophilia treatments https://researchconnect.buffalo.edu/en/publications/quantitative-structure-pharmacokinetic-relationships-for-the-pred/ Quantitative structure-pharmacokinetic relationships for the prediction of renal clearance in... for the quantitative structure pharmacokinetic relationships https://pep-azide.com/index.php?g=Wap&m=Article&a=detail&id=15796 Phenacetin in Advanced In Vitro Pharmacokinetic Modeling advanced vitro pharmacokinetic modeling https://www.page-meeting.org/Abstracts/cyclophosphamide-methotrexate-and-5-fluorouracil-population-pharmacokinetic-models-with-pharmacogenetic-covariates/ Cyclophosphamide, Methotrexate, and 5-Fluorouracil Population Pharmacokinetic Models with... Oct 21, 2025 - Poster: Applications- Oncology - Cyclophosphamide, Methotrexate, and 5-Fluorouracil Population Pharmacokinetic Models with Pharmacogenetic Covariates cyclophosphamide methotrexate fluorouracil population pharmacokinetic https://www.page-meeting.org/Abstracts/development-of-a-mechanism-based-pharmacokinetic-model-for-mmae-conjugated-adcs/ Development of a Mechanism-based pharmacokinetic model for MMAE conjugated ADCs Oct 21, 2025 - Poster: Drug/Disease modeling - Oncology - Development of a Mechanism-based pharmacokinetic model for MMAE conjugated ADCs development mechanism based https://www.epistemonikos.org/en/documents/6e25db5ae0a4260a499e0259b20ddc15039d08be Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis... The Purpose of this study is to characterize the single and multiple-dose pharmacokinetic (PK) and pharmacokinetic/pharmacodynamic (PK/ PD) profiles after or... safety and efficacy pharmacokinetic study rivaroxaban https://adisinsight.springer.com/trials/700054151?error=cookies_not_supported&code=3ef3a02b-5955-456b-8430-7c0e1a180b18 A Phase I Pharmacokinetic Study of Intraperitoneal CTEP-Supplied Agent Bortezomib (PS-341, NSC... This trial is investigating the tolerability, efficacy and pharmacokinetics of intraperitoneal bortezomib and carboplatin in patients with persistent or https://www.page-meeting.org/Abstracts/population-pharmacokinetic-poppk-analysis-of-tenofovir-alafenamide-taf-and-tenofovir-tfv-in-children-with-hiv-1-%E2%89%A51-month-of-age/ Population pharmacokinetic (popPK) analysis of tenofovir alafenamide (TAF) and tenofovir (TFV) in... May 12, 2026 - Introduction/Objectives: Tenofovir alafenamide (TAF) is a second generation oral prodrug of tenofovir (TFV), a nucleotide analog that inhibits HIV type... tenofovir alafenamide population pharmacokinetic analysis https://materialsmetric.com/pharmacokinetic-pharmacometric-modeling/ Pharmacokinetic & Pharmacometric Modeling | Materials Metric Dec 24, 2025 - Pharmacokinetic (PK) and pharmacometric (PMX) modeling predict exposure, optimize dosing, and support preclinical-to-clinical translation modeling materials pharmacokinetic metric https://archive.hshsl.umaryland.edu/entities/publication/3a4c1a13-798f-4c9c-b9be-5774968a2d6a Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody caStx2... Hemolytic-uremic syndrome (HUS) is a serious complication of infection by Shiga toxin-producing Escherichia coli. Shiga toxin type 2 (Stx2) is responsible for... https://ctv.veeva.com/study/a-pharmacokinetic-study-of-three-different-particle-sizes-of-ph797804 A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 The purpose of this study is to investigate the effects of varying particle size on the pharmacokinetics of PH-797804 pharmacokinetic study three different particle https://researchinformation.umcutrecht.nl/en/publications/pharmacokinetic-optimization-of-everolimus-dosing-in-oncology-a-r/ Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial -... pharmacokinetic optimization everolimus dosing https://thenursinggeeks.com/2021/11/pharmacokinetic-and-pharmacodynamics-processes-of-a-patient/ pharmacokinetic and pharmacodynamics processes of a patient - The Nursing Geeks Nov 29, 2021 - Analyze factors that may influence pharmacokinetic and pharmacodynamics processes of a patient and assess the details of a personalized plan of care that you a patient pharmacokinetic pharmacodynamics processes nursing https://research.knu.ac.kr/en/publications/pharmacokinetic-analysis-and-biomarker-assisted-safety-assessment/ Pharmacokinetic Analysis and Biomarker-Assisted Safety Assessment of Acetaminophen in Combination... safety assessment pharmacokinetic analysis biomarker assisted https://www.advarra.com/learn/clinical-trials-acronyms/pharmacokinetic/ Pharmacokinetic (PK) - Clinical Trials Acronym | Advarra Mar 11, 2026 - Pharmacokinetic (PK) describes how the body absorbs, distributes, metabolizes, and eliminates a drug, typically measured through concentration over time. clinical trials pharmacokinetic pk acronym https://adisinsight.springer.com/trials/700365244?error=cookies_not_supported&code=379f763d-69c3-43b6-b35f-79c23e9862d7 A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics... A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-341. https://www.epistemonikos.org/en/documents/6abeb92a6cc22a603a92308faa02967f16b66ee7 Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy... The purpose of this study is to assess the pharmacokinetic characteristics of olmesartan and S-amlodipine after single oral administration of Sevikar tab. 10... https://www.epistemonikos.org/en/documents/3c5d884a741915d062ba7497892782f274fb0065 To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers To evaluate and compare the pharmacokinetic interactions and safety of multiple dose of Treatment A and Treatment B alone and in combination evaluate pharmacokinetic interactions safety healthy https://research.uniupo.it/en/publications/intrapatient-and-interpatient-pharmacokinetic-variability-of-ralt/ Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting -... in the pharmacokinetic variability https://repository.must.ac.ke/handle/123456789/462 Safety, Pharmacokinetic, and Efficacy Studies of Oral DB868 in a First Stage Vervet Monkey Model of... https://adisinsight.springer.com/trials/700369026?error=cookies_not_supported&code=9ec31977-95ea-40c7-87e8-37708d812808 Safety, Tolerability and Pharmacokinetic Characteristics of JYP0061 in Healthy Adult Subjects After... The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of JYP0061 in healthy adult subjects. The main https://www.page-meeting.org/Abstracts/re-writing-oral-pharmacokinetics-using-physiologically-based-finite-time-pharmacokinetic-pbftpk-models/ Re-writing oral pharmacokinetics using physiologically based finite time pharmacokinetic (PBFTPK)... Oct 21, 2025 - Poster: Methodology - New Modelling Approaches - Re-writing oral pharmacokinetics using physiologically based finite time pharmacokinetic (PBFTPK) models writing oral pharmacokinetics using https://ctv.veeva.com/study/a-pharmacokinetic-substudy-of-the-tde-ph-304-protocol A Pharmacokinetic Substudy of the TDE-PH-304 Protocol A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of patients transitioning from a twice daily dosing regimen of oral treprostinil to a... of the pharmacokinetic tde protocol https://www.chdr.nl/trial-services/pk-and-pd-bioanalysis Pharmacokinetic and -dynamic assays | CHDR pharmacokinetic dynamic assays https://essaypapershq.com/describe-factors-that-might-have-influenced-pharmacokinetic-and-pharmacodynamic-processes/ describe factors that might have influenced pharmacokinetic and pharmacodynamic processes - Essay... Sep 4, 2019 - Write a description of the patient case from your experiences, observations, and/or clinical practice from the last 5 years. Then, describe factors that might describe factors might